Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Explore effective ways to get paid this week and take control of your financial situation quickly.
13,202 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
A major air campaign demonstrated how layered airpower blends stealth, electronic warfare, and precision munitions. I...
United Airlines faces near term pressure from higher fuel costs, yet the Street remains optimistic with a consensus t...
As market volatility persists in March 2026, traders are eyeing best stocks under $10 for potential gains. The group ...
Solana climbs toward the $100 threshold as institutional ETF demand and rising open interest boost the token’s moment...
Bitcoin hovers near $74,000 as market eyes Powell and the Fed. An analyst warns of a repeat sell-the-news pattern, ev...
River surged 50% over the past week, trading near $26, as analysts split on whether the rally signals a new uptrend o...
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
Analysts see a wall street pros upside for Royal Caribbean as 2026 capacity and earnings guidance point to a stronger...
A notorious short-seller unloaded sofi this week with sweeping accusations, but the stock shrugged off most of the blow.
Friday's session put cybersecurity stocks in retreat as investors priced in AI-driven commoditization risks. Palo Alt...
CME is moving to introduce Bitcoin volatility futures that track market expectations of price swings, separate from B...